๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Detailed microsatellite analysis of chromosome 3p region in non-papillary renal cell carcinomas

โœ Scribed by Jerzy Chudek; Monica Wilhelm; Peter Bugert; Jutta Herbers; Gyula Kovacs


Publisher
John Wiley and Sons
Year
1997
Tongue
French
Weight
147 KB
Volume
73
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

โœฆ Synopsis


Multiple hemi-and homozygous interstitial deletions at chromosome 3p have been found in different types of cancer, including non-papillary renal cell carcinoma (RCC). To determine the frequency and size of deletions, we have analyzed paired normal and tumor DNA obtained from short-term cultures of 104 non-papillary RCCs with 29 microsatellite markers covering the entire chromosome 3p region. Deletion mapping provided evidence for terminal deletion, with the most distal breakpoint between loci D3S1606 and D3S3666 in 94 cases, whereas constitutional heterozygosity was retained at all loci in 4 RCCs. In 6 cases, interstitial deletions were detected. Deletion mapping detected the smallest overlapping region between loci D3S3666 and D3S1560, which corresponds to an approx. 55 cM genetic distance.


๐Ÿ“œ SIMILAR VOLUMES


Duplication of two distinct regions on c
โœ Peter Bugert; Rolf Von Knobloch; Gyula Kovacs ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 97 KB ๐Ÿ‘ 2 views

RFLP studies have indicated a duplication of DNA sequences at the chromosome 5q22 region and showed a breakpoint cluster between the apc and mcc genes in nonpapillary renal-cell carcinoma (RCC). We have now made a high-density fluorescent microsatellite assay to investigate the allelic status and de

Microsatellite analysis reveals deletion
โœ Dietlinde Schullerus; Rolf von Knobloch; Jerzy Chudek; Jutta Herbers; Gyula Kova ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 83 KB ๐Ÿ‘ 1 views

Loss of heterozygosity (LOH) at chromosome 8p is associated with the progression of conventional (non-papillary) renal cell carcinomas (RCC). To determine the tumor suppressor gene locus, we carried out a deletion mapping of chromosome 8p at 10 microsatellite loci in 96 RCCs. LOH occurred in 32% of

Detailed deletion mapping at chromosome
โœ Kenji Okami; Paul Cairns; William H. Westra; Jurgen F. Linn; Steven A. Ahrendt; ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 159 KB ๐Ÿ‘ 1 views

We examined 82 cases of primary non-small cell lung cancer (NSCLC) for loss of heterozygosity (LOH) at the chromosome 9p21-24 region using 16 microsatellite markers. A total of 52 tumors (63%) displayed LOH, and 25 of these cases displayed LOH for all markers. Two cases had small hemizygous losses c

Loss of heterozygosity at chromosomes 8p
โœ Schullerus, Dietlinde; Herbers, Jutta; Chudek, Jerzy; Kanamaru, Hiroshi; Kovacs, ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 92 KB ๐Ÿ‘ 1 views

In this study, 105 non-papillary renal cell carcinomas (RCCs) have been examined for allelic loss at the chromosome 8p12-21.1, 9p21, and 14q24.2-qter regions, each by two highly polymorphic microsatellites. Loss of heterozygosity (LOH) was detected at both chromosome 8p and 9p in 33 per cent of the

Loss of expression of the DRR 1 gene at
โœ Liang Wang; John Darling; Jin-San Zhang; Wanguo Liu; Junqi Qian; David Bostwick; ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 256 KB ๐Ÿ‘ 2 views

Consistent deletion of DNA sequences in chromosomal band 3p21 observed in a variety of human tumors suggests the presence of one or more tumor suppressor genes within this region. Previously, we reported on the construction of two distinct cosmid contigs and our identification of several new genes w

Expression of p16INK4A and alterations o
โœ George Mariatos; Vassilis G. Gorgoulis; Panayotis Zacharatos; Athanassios Kotsin ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 286 KB ๐Ÿ‘ 1 views

The 9p21-23 chromosome region harbors a number of known and putative tumor-suppressor genes (TSGs). The best characterized gene in this area is p16 INK4A (CDKN2A). Alterations of its product have been observed in various malignancies, including non-small-cell lung carcinomas (NSCLCs). We earlier inv